Clinical studies recruiting near Cologne

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Observational Study Protocol: LIVER-R
Phase N/A · Research Site · AstraZeneca · NCT06252753 A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Phase 3 · Studienzentrum Bayenthal Urologische Partnerschaft Köln · Eli Lilly and Company · NCT07218380 Continuous Delivery Room Skin-to-skin-study for Moderate and Late Preterm Infants
NA · University hospital of Cologne, Department of Neonatology · University of Cologne · NCT05975203 Efficacy and Safety of MB-CART2019.1 vs. SoC in Lymphoma Patients
Phase 2 · Universitaetsklinikum Koeln · Miltenyi Biomedicine GmbH · NCT04844866 Niraparib vs Niraparib Plus Bevacizumab in Patients With Platinum/Taxane-based Chemotherapy in Advanced Ovarian Cancer
Phase 3 · St. Elisabeth-Krankenhaus Köln-Hohenlind · AGO Study Group · NCT05009082 PODOMOUNT-Basket, a Study to Test Whether BI 764198 Helps Adults and Adolescents With Different Types of Kidney Disease
Phase 2 · Universitätsklinikum Köln (AöR) · Boehringer Ingelheim · NCT07355296 A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants Wit
Phase 1/Phase 2 · Local Institution - 0031 · Bristol-Myers Squibb · NCT07291076 Safety and Preliminary Efficacy of CTX112 in Adult Participants With Relapsed/Refractory Hematologic Autoimmune Disease
Phase 1/Phase 2 · Universitaetsklinikum Koeln · CRISPR Therapeutics AG · NCT07549698 A Study on the Tolerability, Safety and Effectiveness of Asciminib in Patients With Philadelphia Chromosome-positive Chr
Phase N/A · Novartis Investigative Site · Novartis Pharmaceuticals · NCT07549516 Real-World Clinical Experience of Patients With Metastatic Castration-Resistant Prostate Cancer Treated With Olaparib +
Phase N/A · Research Site · AstraZeneca · NCT06380738 Endometrial Cancer Lymphadenectomy Trial
NA · Evangelisches Krankenhaus Kalk gGmbH, Gynäkologie und Geburt · Philipps University Marburg · NCT03438474 A Study of Rapcabtagene Autoleucel in Active, Refractory Systemic Lupus Erythematosus (SLE) or Lupus Nephritis (LN) Pati
Phase 2 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT06581198 European Larynx Organ Preservation Study (ELOS) [MK-3475-C44]
Phase 2 · Universitätsklinikum Köln, Klinik für Hals-, Nasen-, Ohrenhe · University of Leipzig · NCT06137378 Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS
Phase 3 · MV-Zentrum für Onkologie und Hämatologie · Eli Lilly and Company · NCT06890598 A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangement
Phase 1/Phase 2 · Local Institution - 4701 · Turning Point Therapeutics, Inc. · NCT03093116 A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Child
Phase 3 · Universitätsklinikum Köln - Kinderkardiologie · Bayer · NCT07192952 A Clinical Study to Compare BupiZenge With Lidocaine for Pain Due to Oral Mucositis in Patients With Head and Neck Cance
Phase 3 · University Hospital Cologne (Universitätsklinikum Köln AöR) · OncoZenge AB · NCT07672236 Blood Flow Restriction Training in Acute Geriatric Rehabilitation
NA · St. Marien-Hospital Köln · University Hospital, Bonn · NCT07291765 International HIT-MED Registry (I-HIT-MED)
Phase N/A · University Hospital Cologne · Universitätsklinikum Hamburg-Eppendorf · NCT02417324 Study to Assess Safety of HDP-101 in Patients With Relapsed Refractory Multiple Myeloma
Phase 1/Phase 2 · Universitätsklinikum Köln · Heidelberg Pharma AG · NCT04879043 Efficacy of INM004 in Children With STEC-HUS
Phase 3 · University Hospital Cologne AöR · Inmunova S.A. · NCT06389474 Investigation of the Audible ICD Alert Tone
Phase N/A · University Hospital Cologne · Universitätsklinikum Köln · NCT06388382 PROOFS-Registry - Premenopausal Women With Breast Cancer Optimally Treated With OFS
Phase N/A · Kliniken der Stadt Köln · Women's Cancer Study Group GmbH · NCT05792150 Alpelisib in Pediatric and Adult Patients With Lymphatic Malformations Associated With a PIK3CA Mutation.
Phase 2/Phase 3 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT05948943 KetoNiFast: Cyclic Enteral Daytime Feeding With Ketogenic Nighttime Fasting
NA · Department of Anesthesiology and Intensive Care Medicine · University Hospital of Cologne · NCT06535815 GMALL Registry and Collection of Biomaterial: Prospective Data Collection Regarding Diagnosis, Treatment and Outcome of
Phase N/A · Universitätsklinikum Köln · Goethe University · NCT02872987 Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis
Phase N/A · Research Site · AstraZeneca · NCT06465810 A Study to Evaluate the Benefits and Risks of Conversion of Existing Adolescent Kidney Transplant Recipients Aged 12 to
Phase 3 · Universitaetsklinikum Koeln-Klinik und Poliklinik für Kinder · Bristol-Myers Squibb · NCT04877288 To Assess the Efficacy, Safety, and Tolerability of INCB000928 in Participants With Fibrodysplasia Ossificans Progressiv
Phase 2 · Uniklinik Koln · Incyte Corporation · NCT05090891 A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in Fi
Phase 3 · Krankenhaus Koeln-Merheim - Kliniken der Stadt Koeln gGmbH · Amgen · NCT07005128

Look up another city

Look up another condition